Patient Leaflet Updated 09-Oct-2017 | Bayer plc
Nimotop 30mg Tablets
Due to regulatory changes, the content of the following Patient Information Leaflet may vary from the one found in your medicine pack. Please compare the 'Leaflet prepared/revised date' towards the end of the leaflet to establish if there have been any changes.
If you have any doubts or queries about your medication, please contact your doctor or pharmacist.
Nimotop® 30 mg Tablets
Nimodipine
1. What Nimotop tablets are and what they are used for
2. What you need to know before you take Nimotop tablets
3. How to take Nimotop tablets
4. Possible side effects
5. How to store Nimotop tablets
6. Contents of the pack and other information
Nimotop tablets contains nimodipine, which belongs to a group of medicines called calcium antagonists.
Nimotop tablets are used to prevent changes in brain function after bleeding around the brain (subarachnoid haemorrhage).
Talk to your doctor or pharmacist before taking Nimotop tablets
Do not give Nimotop tablets to children under the age of 18 as the safety and efficacy of Nimotop have not been established.
You will not be given Nimotop tablets if you are receiving Nimotop Solution.
You are not to be given rifampicin (an antibiotic), phenobarbital, phenytoin, or carbamazepine (anti-epileptic drugs) if you are taking Nimotop tablets.
Tell your doctor if you are taking, have recently taken or might take any other medicines.
Some medicines may affect the way Nimotop tablets works. Tell your doctor if you are taking:
You can take Nimotop tablets with or without food.
Do not drink grapefruit juice or eat grapefruit while taking Nimotop tablets.
Do not start taking Nimotop tablets within 4 days of drinking grapefruit juice or eating grapefruit. Tell your doctor if you have had grapefruit or grapefruit juice in this time. Also, do not drink grapefruit juice or eat grapefruit whilst taking Nimotop tablets. Grapefruit juice is known to increase the blood levels of the active ingredient, nimodipine. This effect can last for at least four days.
If you are pregnant, think you may be pregnant or are planning to have a baby, ask your doctor for advice before taking this medicine. Follow his/her instructions carefully.
Do not breast-feed while taking Nimotop tablets.
If you are trying to father a child, talk to your doctor. Medicines like Nimotop tablets can sometimes affect male fertility.
Nimotop tablets may make you feel dizzy. Do not drive or operate machinery if you are affected in this way.
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
Swallow the tablets with a little water.
Do not take more than your doctor has prescribed.
Take your normal dose immediately and carry on taking that day’s tablets at 4-hour intervals.
Do not take a double dose to make up for the forgotten tablets.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
If you experience:
In addition to the serious side effects listed above, these are the other less serious side effects of Nimotop tablets:
Uncommon side effects
(These may affect less than 1 in 100 people)
Rare side effects
(These may affect less than 1 in 1,000 people)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not store above 30°C.
Do not use this medicine after the expiry date which is stated on both the outer carton and on each blister strip of tablets after EXP. The expiry date refers to the last day of that month.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is nimodipine. Each film-coated tablet contains 30 mg of nimodipine.
The other ingredients are microcrystalline cellulose, hypromellose, macrogol, maize starch, povidone, crospovidone, magnesium stearate and the colourings titanium dioxide (E171) and iron oxide yellow (E172).
The tablets come in boxes of 100, but your doctor will prescribe as many as you need.
Marketing Authorisation holder:
Manufacturer:
This leaflet was last revised in August 2017.
Product Licence Number: PL 00010/0137
020_0
400 South Oak Way, Reading, Berkshire, RG2 6AD
+44 (0)118 206 3000